 | • レポートコード：QFJ1-5828 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ラパチニブの市場動向 ・企業の競争状況、市場シェア ・ラパチニブの種類別市場規模と予測2016-2027（250mg錠、タイプII） ・ラパチニブの用途別市場規模と予測2016-2027（病院、ドラッグストア） ・ラパチニブの北米市場規模2016-2027（アメリカ、カナダ） ・ラパチニブの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ラパチニブのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ラパチニブの中南米市場規模2016-2027（メキシコ、ブラジル） ・ラパチニブの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis） ・結論 |
Lapatinib (INN), used in the form of lapatinib ditosylate (USAN) (trade names Tykerb and Tyverb) is an orally active drug for breast cancer and other solid tumours.
Market Analysis and Insights: Global Lapatinib Market
The global Lapatinib market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lapatinib market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lapatinib market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lapatinib market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lapatinib market.
Global Lapatinib Scope and Market Size
Lapatinib market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lapatinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
250 mg Tablets
Type II
Segment by Application
Hospital
Drug store
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lapatinib Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 250 mg Tablets
1.2.3 Type II
1.3 Market by Application
1.3.1 Global Lapatinib Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lapatinib Market Perspective (2016-2027)
2.2 Lapatinib Growth Trends by Regions
2.2.1 Lapatinib Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lapatinib Historic Market Share by Regions (2016-2021)
2.2.3 Lapatinib Forecasted Market Size by Regions (2022-2027)
2.3 Lapatinib Industry Dynamic
2.3.1 Lapatinib Market Trends
2.3.2 Lapatinib Market Drivers
2.3.3 Lapatinib Market Challenges
2.3.4 Lapatinib Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lapatinib Players by Revenue
3.1.1 Global Top Lapatinib Players by Revenue (2016-2021)
3.1.2 Global Lapatinib Revenue Market Share by Players (2016-2021)
3.2 Global Lapatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lapatinib Revenue
3.4 Global Lapatinib Market Concentration Ratio
3.4.1 Global Lapatinib Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lapatinib Revenue in 2020
3.5 Lapatinib Key Players Head office and Area Served
3.6 Key Players Lapatinib Product Solution and Service
3.7 Date of Enter into Lapatinib Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lapatinib Breakdown Data by Type
4.1 Global Lapatinib Historic Market Size by Type (2016-2021)
4.2 Global Lapatinib Forecasted Market Size by Type (2022-2027)
5 Lapatinib Breakdown Data by Application
5.1 Global Lapatinib Historic Market Size by Application (2016-2021)
5.2 Global Lapatinib Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Lapatinib Market Size (2016-2027)
6.2 North America Lapatinib Market Size by Type
6.2.1 North America Lapatinib Market Size by Type (2016-2021)
6.2.2 North America Lapatinib Market Size by Type (2022-2027)
6.2.3 North America Lapatinib Market Size by Type (2016-2027)
6.3 North America Lapatinib Market Size by Application
6.3.1 North America Lapatinib Market Size by Application (2016-2021)
6.3.2 North America Lapatinib Market Size by Application (2022-2027)
6.3.3 North America Lapatinib Market Size by Application (2016-2027)
6.4 North America Lapatinib Market Size by Country
6.4.1 North America Lapatinib Market Size by Country (2016-2021)
6.4.2 North America Lapatinib Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Lapatinib Market Size (2016-2027)
7.2 Europe Lapatinib Market Size by Type
7.2.1 Europe Lapatinib Market Size by Type (2016-2021)
7.2.2 Europe Lapatinib Market Size by Type (2022-2027)
7.2.3 Europe Lapatinib Market Size by Type (2016-2027)
7.3 Europe Lapatinib Market Size by Application
7.3.1 Europe Lapatinib Market Size by Application (2016-2021)
7.3.2 Europe Lapatinib Market Size by Application (2022-2027)
7.3.3 Europe Lapatinib Market Size by Application (2016-2027)
7.4 Europe Lapatinib Market Size by Country
7.4.1 Europe Lapatinib Market Size by Country (2016-2021)
7.4.2 Europe Lapatinib Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Lapatinib Market Size (2016-2027)
8.2 Asia-Pacific Lapatinib Market Size by Type
8.2.1 Asia-Pacific Lapatinib Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lapatinib Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lapatinib Market Size by Type (2016-2027)
8.3 Asia-Pacific Lapatinib Market Size by Application
8.3.1 Asia-Pacific Lapatinib Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lapatinib Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lapatinib Market Size by Application (2016-2027)
8.4 Asia-Pacific Lapatinib Market Size by Region
8.4.1 Asia-Pacific Lapatinib Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lapatinib Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lapatinib Market Size (2016-2027)
9.2 Latin America Lapatinib Market Size by Type
9.2.1 Latin America Lapatinib Market Size by Type (2016-2021)
9.2.2 Latin America Lapatinib Market Size by Type (2022-2027)
9.2.3 Latin America Lapatinib Market Size by Type (2016-2027)
9.3 Latin America Lapatinib Market Size by Application
9.3.1 Latin America Lapatinib Market Size by Application (2016-2021)
9.3.2 Latin America Lapatinib Market Size by Application (2022-2027)
9.3.3 Latin America Lapatinib Market Size by Application (2016-2027)
9.4 Latin America Lapatinib Market Size by Country
9.4.1 Latin America Lapatinib Market Size by Country (2016-2021)
9.4.2 Latin America Lapatinib Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lapatinib Market Size (2016-2027)
10.2 Middle East & Africa Lapatinib Market Size by Type
10.2.1 Middle East & Africa Lapatinib Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lapatinib Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lapatinib Market Size by Type (2016-2027)
10.3 Middle East & Africa Lapatinib Market Size by Application
10.3.1 Middle East & Africa Lapatinib Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lapatinib Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lapatinib Market Size by Application (2016-2027)
10.4 Middle East & Africa Lapatinib Market Size by Country
10.4.1 Middle East & Africa Lapatinib Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lapatinib Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Lapatinib Introduction
11.1.4 Novartis Revenue in Lapatinib Business (2016-2021)
11.1.5 Novartis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Lapatinib Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 250 mg Tablets
Table 3. Key Players of Type II
Table 4. Global Lapatinib Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Lapatinib Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Lapatinib Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Lapatinib Market Share by Regions (2016-2021)
Table 8. Global Lapatinib Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Lapatinib Market Share by Regions (2022-2027)
Table 10. Lapatinib Market Trends
Table 11. Lapatinib Market Drivers
Table 12. Lapatinib Market Challenges
Table 13. Lapatinib Market Restraints
Table 14. Global Lapatinib Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Lapatinib Market Share by Players (2016-2021)
Table 16. Global Top Lapatinib Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lapatinib as of 2020)
Table 17. Ranking of Global Top Lapatinib Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Lapatinib Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Lapatinib Product Solution and Service
Table 21. Date of Enter into Lapatinib Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lapatinib Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Lapatinib Revenue Market Share by Type (2016-2021)
Table 25. Global Lapatinib Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Lapatinib Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Lapatinib Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Lapatinib Revenue Market Share by Application (2016-2021)
Table 29. Global Lapatinib Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Lapatinib Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Lapatinib Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Lapatinib Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Lapatinib Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Lapatinib Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Lapatinib Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Lapatinib Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Lapatinib Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Lapatinib Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Lapatinib Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Lapatinib Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Lapatinib Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Lapatinib Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Lapatinib Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Lapatinib Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lapatinib Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lapatinib Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lapatinib Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Lapatinib Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Lapatinib Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Lapatinib Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Lapatinib Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Lapatinib Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Lapatinib Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Lapatinib Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Lapatinib Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Lapatinib Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lapatinib Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lapatinib Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lapatinib Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Lapatinib Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Lapatinib Product
Table 64. Novartis Revenue in Lapatinib Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lapatinib Market Share by Type: 2020 VS 2027
Figure 2. 250 mg Tablets Features
Figure 3. Type II Features
Figure 4. Global Lapatinib Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Lapatinib Report Years Considered
Figure 8. Global Lapatinib Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Lapatinib Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Lapatinib Market Share by Regions: 2020 VS 2027
Figure 11. Global Lapatinib Market Share by Regions (2022-2027)
Figure 12. Global Lapatinib Market Share by Players in 2020
Figure 13. Global Top Lapatinib Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lapatinib as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Lapatinib Revenue in 2020
Figure 15. Global Lapatinib Revenue Market Share by Type (2016-2021)
Figure 16. Global Lapatinib Revenue Market Share by Type (2022-2027)
Figure 17. North America Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Lapatinib Market Share by Type (2016-2027)
Figure 19. North America Lapatinib Market Share by Application (2016-2027)
Figure 20. North America Lapatinib Market Share by Country (2016-2027)
Figure 21. United States Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Lapatinib Market Share by Type (2016-2027)
Figure 25. Europe Lapatinib Market Share by Application (2016-2027)
Figure 26. Europe Lapatinib Market Share by Country (2016-2027)
Figure 27. Germany Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Lapatinib Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Lapatinib Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Lapatinib Market Share by Region (2016-2027)
Figure 37. China Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Lapatinib Market Share by Type (2016-2027)
Figure 45. Latin America Lapatinib Market Share by Application (2016-2027)
Figure 46. Latin America Lapatinib Market Share by Country (2016-2027)
Figure 47. Mexico Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Lapatinib Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Lapatinib Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Lapatinib Market Share by Country (2016-2027)
Figure 53. Turkey Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Lapatinib Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Novartis Revenue Growth Rate in Lapatinib Business (2016-2021)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …- 世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
- 世界のマラビロク市場規模・現状・予測（2021年-2027年） Maraviroc is an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection. Market Analysis and Insights: Global Maraviroc Market The global Maraviroc market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …
- 世界のデシタビン薬市場規模・現状・予測（2021年-2027年） Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML). Market Analysis and Insights:…
- 世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypothyroidism Drug Market The global Hypothyroidism Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…